OTC and acute lymphoblastic leukemia: Of 13 pediatric pre‐B ALL samples, 7% had no staining, 32% had low and 54% had moderate ASS expression and 7% had high expression; while 0% had no staining, 15% had low, 70% had moderate and 15% had high OTC expression (Fig. 3d, bottom panel).